SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for UPXI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 5.485M
December 31, 2025 6.439M
September 30, 2025 10.32M
June 30, 2025 7.347M
March 31, 2025 3.682M
December 31, 2024 2.499M
September 30, 2024 2.409M
March 31, 2024 3.946M
December 31, 2023 4.995M
September 30, 2023 5.105M
June 30, 2023 2.424M
March 31, 2023 4.861M
December 31, 2022 5.815M
Date Value
September 30, 2022 3.855M
June 30, 2022 3.881M
March 31, 2022 1.691M
December 31, 2021 4.739M
September 30, 2021 2.582M
June 30, 2021 4.223M
March 31, 2021 2.295M
December 31, 2020 2.005M
September 30, 2020 1.949M
June 30, 2020 1.698M
March 31, 2020 1.610M
December 31, 2019 1.793M
September 30, 2019 1.543M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Stephan Co. 1.146M
Synergy CHC Corp. 4.505M
Kenvue, Inc. 1.453B
Reliv' International, Inc. 2.558M
Natural Health Trends Corp. 7.377M